Forte Biosciences, Inc. ($FBRX)
Filing Information
| Accession Number | 0001339375-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 2, 2026 |
| Document Date | Dec 30, 2025 |
| Document | View SEC Filing |
Transactions
4
Total Shares
10,584
Total Value
$259,032.36
P&L
-10.7% ($27,352.78)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF FINANCIAL OFFICER | Common Stock | โ | Dec 30, 2025 | Purchase | 9,680 | $26.33 | $254,832.78 | 41,520 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | Jan 1, 2026 | Exercise/Conversion | 375 | $0.00 | $0.00 | 41,895 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | Jan 1, 2026 | Tax Withholding | 154 | $27.27 | $4,199.58 | 41,741 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Restricted Stock Units | Derivative | Jan 1, 2026 | Exercise/Conversion | 375 | $0.00 | $0.00 | 1,500 | Direct | โ | View Details |